BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12771199)

  • 1. Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ.
    Bristow CA; Shore P
    Nucleic Acids Res; 2003 Jun; 31(11):2735-44. PubMed ID: 12771199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma.
    Choi SJ; Oba T; Callander NS; Jelinek DF; Roodman GD
    Blood; 2003 May; 101(10):3778-83. PubMed ID: 12560229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
    Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
    PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.
    Kitabayashi I; Aikawa Y; Nguyen LA; Yokoyama A; Ohki M
    EMBO J; 2001 Dec; 20(24):7184-96. PubMed ID: 11742995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.
    Spender LC; Whiteman HJ; Karstegl CE; Farrell PJ
    Oncogene; 2005 Mar; 24(11):1873-81. PubMed ID: 15688019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
    Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES
    Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements.
    Puig-Kröger A; Sanchez-Elsner T; Ruiz N; Andreu EJ; Prosper F; Jensen UB; Gil J; Erickson P; Drabkin H; Groner Y; Corbi AL
    Blood; 2003 Nov; 102(9):3252-61. PubMed ID: 12855590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AML1/ETO fusion protein activates transcription of BCL-2.
    Klampfer L; Zhang J; Zelenetz AO; Uchida H; Nimer SD
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14059-64. PubMed ID: 8943060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.
    Liu S; Shen T; Huynh L; Klisovic MI; Rush LJ; Ford JL; Yu J; Becknell B; Li Y; Liu C; Vukosavljevic T; Whitman SP; Chang KS; Byrd JC; Perrotti D; Plass C; Marcucci G
    Cancer Res; 2005 Feb; 65(4):1277-84. PubMed ID: 15735013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
    Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages.
    Himes SR; Cronau S; Mulford C; Hume DA
    Oncogene; 2005 Aug; 24(34):5278-86. PubMed ID: 16007221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
    Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M
    Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B.
    Frank R; Zhang J; Uchida H; Meyers S; Hiebert SW; Nimer SD
    Oncogene; 1995 Dec; 11(12):2667-74. PubMed ID: 8545124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core binding factor genes and human leukemia.
    Hart SM; Foroni L
    Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1.
    Oakford PC; James SR; Qadi A; West AC; Ray SN; Bert AG; Cockerill PN; Holloway AF
    Leuk Res; 2010 Sep; 34(9):1203-13. PubMed ID: 20439113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/EBP, NF-kappa B, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1 alpha immediate-early gene.
    Grove M; Plumb M
    Mol Cell Biol; 1993 Sep; 13(9):5276-89. PubMed ID: 8355682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
    Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
    J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of tissue inhibitor of metalloproteinase 1 gene transcription by RUNX1 and RUNX2.
    Bertrand-Philippe M; Ruddell RG; Arthur MJ; Thomas J; Mungalsingh N; Mann DA
    J Biol Chem; 2004 Jun; 279(23):24530-9. PubMed ID: 15051730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2.
    Pelletier N; Champagne N; Stifani S; Yang XJ
    Oncogene; 2002 Apr; 21(17):2729-40. PubMed ID: 11965546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S; Lenny N; Sun W; Hiebert SW
    Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.